Architect Reagents
Device
Abbott Laboratories
Total Payments
$331,781
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $331,781 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $331,781 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Abbott-Duke PROMISE Trial Biomaker Substudy | Abbott Laboratories | $331,781 | 0 |
Top Doctors Receiving Payments for Architect Reagents
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Durham, NC | $331,781 | 3 |
Ad
Manufacturing Companies
- Abbott Laboratories $331,781
Product Information
- Type Device
- Total Payments $331,781
- Total Doctors 0
- Transactions 3
About Architect Reagents
Architect Reagents is a device associated with $331,781 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2019. In 2019, $331,781 was paid across 3 transactions to 0 doctors.
The most common payment nature for Architect Reagents is "Unspecified" ($331,781, 100.0% of total).
Architect Reagents is associated with 1 research study, including "Abbott-Duke PROMISE Trial Biomaker Substudy" ($331,781).